Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Payables (2023 - 2025)

Historic Payables for Cannabis Bioscience International Holdings (CBIH) over the last 6 years, with Q3 2025 value amounting to $213018.0.

  • Cannabis Bioscience International Holdings' Payables fell 1442.69% to $213018.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $213018.0, marking a year-over-year decrease of 1442.69%. This contributed to the annual value of $212065.0 for FY2025, which is 2979.19% down from last year.
  • Cannabis Bioscience International Holdings' Payables amounted to $213018.0 in Q3 2025, which was down 1442.69% from $212065.0 recorded in Q2 2025.
  • Cannabis Bioscience International Holdings' 5-year Payables high stood at $364788.0 for Q4 2023, and its period low was $82660.0 during Q4 2024.
  • In the last 3 years, Cannabis Bioscience International Holdings' Payables had a median value of $232706.0 in 2023 and averaged $222483.2.
  • Over the last 5 years, Cannabis Bioscience International Holdings' Payables had its largest YoY gain of 2979.98% in 2024, and its largest YoY loss of 7734.03% in 2024.
  • Quarter analysis of 3 years shows Cannabis Bioscience International Holdings' Payables stood at $364788.0 in 2023, then tumbled by 77.34% to $82660.0 in 2024, then skyrocketed by 157.7% to $213018.0 in 2025.
  • Its Payables was $213018.0 in Q3 2025, compared to $212065.0 in Q2 2025 and $83117.0 in Q1 2025.